Literature DB >> 3114036

Serum thyroid hormone levels in patients with fulminant hepatitis: usefulness of rT3 and the rT3/T3 ratio as prognostic indices.

T Kano, T Kojima, T Takahashi, Y Muto.   

Abstract

To evaluate thyroid function in 19 patients with fulminant hepatitis (FH), we have measured total and free 3,5,3'-triiodothyronine (T3) and thyroxine (T4), 3,3',5'-triiodothyronine (reverse T3, rT3), thyroid-stimulating hormone (TSH) and thyroxin-binding globulin (TBG) in patients with FH, compared with those of 80 patients with other various liver diseases and of 10 healthy controls. Patients with FH showed the lowest values of serum T3 and the highest levels of rT3 among all patients with liver diseases studied. Furthermore, patients with FH showed a significant increase of rT3 in comparison with subacute hepatitis (SAH), "acute-on-chronic" (AOC) type of hepatic failure, ordinary and severe forms of acute hepatitis (AHo and AHs) and decompensated liver cirrhosis (LC-D). In addition, serum T3 and rT3 and the rT3/T3 ratio significantly correlated with prothrombin time (PT) and plasma methionine level. We also found that serum T3 and rT3 concentrations and the rT3/T3 ratio showed early and rapid normalization in cases of FH that survived, but they did not improve in patients with fatal outcome. These results suggest that serum T3, particularly rT3 concentrations and the rT3/T3 ratio may be useful indicators for assessing the severity and prognosis of patients with FH and can be considered to the sensitive indices for functioning hepatic microsomal reserve as well.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114036     DOI: 10.1007/bf02774261

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  19 in total

1.  Regulation of thyroid hormone metabolism in rat liver fractions.

Authors:  B Höffken; R Ködding; A Von Zur Mühlen; T Hehrmann; H Jüppner; R D Hesch
Journal:  Biochim Biophys Acta       Date:  1978-02-13

2.  Iodothyronine metabolism in rat liver homogenates.

Authors:  M M Kaplan; R D Utiger
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

3.  In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses.

Authors:  I J Chopra; G N Teco; A H Nguyen; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1979-07       Impact factor: 5.958

4.  Serum T3 and reverse T3 levels in hepatic cirrhosis: relation to hepatocellular damage and normalization on improvement in liver dysfunction.

Authors:  U M Kabadi; B N Premachandra
Journal:  Am J Gastroenterol       Date:  1983-11       Impact factor: 10.864

5.  A study of extrathyroidal conversion of thyroxine (T4) to 3,3',5-triiodothyronine (T3) in vitro.

Authors:  I J Chopra
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

6.  Reduced peripheral conversion of thyroxine to triiodothyronine in patients with hepatic cirrhosis.

Authors:  S Nomura; C S Pittman; J B Chambers; M W Buck; T Shimizu
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

7.  Serum thyroid hormone levels in patients with liver disease.

Authors:  G W Hepner; I J Chopra
Journal:  Arch Intern Med       Date:  1979-10

8.  Kinetic studies of thyroxine, 3,5,3'-triiodothyronine, 3,3,5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis.

Authors:  J Faber; H F Thomsen; I B Lumholtz; C Kirkegaard; K Siersbaek-Nielsen; T Friis
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

9.  Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3'-triiodothyronine in sera of patients with nonthyroidal illnesses.

Authors:  I J Chopra; T S Huang; A Beredo; D H Solomon; G N Chua Teco; J F Mead
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

10.  Serum thyroid hormone, triiodothyronine, thyroxine, and triiodothyronine/thyroxine ratio in patients with fulminant, acute, and chronic hepatitis.

Authors:  S Itoh; Y Yamaba; T Oda; K Kawagoe
Journal:  Am J Gastroenterol       Date:  1986-06       Impact factor: 10.864

View more
  6 in total

Review 1.  Thyroid hormones and growth in health and disease.

Authors:  Ömer Tarım
Journal:  J Clin Res Pediatr Endocrinol       Date:  2011-06-08

2.  Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure.

Authors:  Olympia Anastasiou; Svenja Sydor; Jan-Peter Sowa; Paul Manka; Antonios Katsounas; Wing-Kin Syn; Dagmar Führer; Robert K Gieseler; Lars P Bechmann; Guido Gerken; Lars C Moeller; Ali Canbay
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

3.  Implication from thyroid function decreasing during chemotherapy in breast cancer patients: chemosensitization role of triiodothyronine.

Authors:  Jianbo Huang; Liangbin Jin; Guangyan Ji; Lei Xing; Chaobo Xu; Xiong Xiong; Hongyuan Li; Kainan Wu; Guosheng Ren; Lingquan Kong
Journal:  BMC Cancer       Date:  2013-07-06       Impact factor: 4.430

4.  Assessment of thyroid and gonadal function in liver diseases.

Authors:  Sandeep Kharb; M K Garg; Pankaj Puri; Karninder S Brar; Aditi Pandit; Sharad Srivastava
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

5.  TSH and Thyrotropic Agonists: Key Actors in Thyroid Homeostasis.

Authors:  Johannes W Dietrich; Gabi Landgrafe; Elisavet H Fotiadou
Journal:  J Thyroid Res       Date:  2012-12-30

Review 6.  Molecular functions of thyroid hormones and their clinical significance in liver-related diseases.

Authors:  Hsiang Cheng Chi; Cheng-Yi Chen; Ming-Ming Tsai; Chung-Ying Tsai; Kwang-Huei Lin
Journal:  Biomed Res Int       Date:  2013-06-26       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.